News and Events

AllPress ReleasesIn the NewsEvents
Press Release

InsightRX Adds Renowned Pharmacology Experts Drs. Richard Peck and Michael Rybak to its Scientific Advisory Board

Press Release

New Study Co-Authored by InsightRX Shows Model-Informed Precision Dosing Could Improve Efficacy of Hematopoietic Cell Transplants While Reducing Toxicity

Press Release

‍Pharmacy and Healthcare Professionals Nationwide Recognize Patient Safety Benefits of New Consensus Vancomycin Dosing Guidelines, But Fewer than One in Three Plan to Adopt Them

Press Release

InsightRX Named Finalist in Accenture's HealthTech Innovation Challenge

Press Release

InsightRX and Premier Inc. Partner to Enable Hospitals, Health Systems and Providers to Individualize Treatment for Infectious Disease Patients

Events

InsightRX presents at the American Conference on Pharmacometrics

Events

InsightRX CSO presents at International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Press Release

Healthcare Technology Startup InsightRX Raises $10 Million to Enable Precision Dosing at Point of Care

Events

InsightRX CEO is a panelist at 12th Annual Cooley Health Tech Conference

Press Release

InsightRX and Children's Hospital Los Angeles (CHLA) to Partner on Precision Dosing

Events

InsightRX CEO to Speak at 2019 JPM Conference

Events

InsightRX CEO is a panelist at "AI Applied to Medicine - How is it impacting us today?"

Events

InsightRX presents at the BIO Investor Forum

Events

Pharmacometrics at the Bedside

Events

InsightRX presents its vision for precision medicine at the HMS Momentum 2018 Conference

In the News

InsightRX wins the Platinum Award at Pulse@MassChallenge

In the News

InsightRX selected to join PULSE@MassChallenge 2018 Program

Events

Model-based TDM in Oncology

In the News

Stanford Children's CMIO Talks Home-grown Clinical Decision Support

In the News

Investing in the Future of Healthcare with OSF Healthcare

In the News

The Right Dose: How Pharmacy Researchers Are Making Medicine More Precise